PubMed · 16879969
Structure-activity relationship study on small peptidic GPR54 agonists.
Abstract
Metastin (kisspeptin-54) is an endogenous ligand that modulates gonadotropin-releasing hormone (GnRH) secretion through the interaction with a G protein-coupled receptor (GPCR), GPR54. The short-chain C-terminal decapeptide amide, metastin (45-54) (kisspeptin-10), exerts the identical bioactivities to metastin, such as metastasis suppression of cancer cells and inhibition of trophoblast migration and invasion. In order to understand the structural requirement for GPR54 agonistic activity, structure-activity relationship (SAR) study on pentapeptide-based C-terminal metastin analogues was carried out. As a result, H-Amb-Nal(2)-Gly-Leu-Arg-Trp-NH2 34 was identified as a novel GPR54 agonist that possessed the most potent GPR54 agonistic activity reported so far.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Kenji Tomita, Ayumu Niida, Shinya Oishi, Hiroaki Ohno, Jérôme Cluzeau, Jean-Marc Navenot, Zi-xuan Wang, Stephen C Peiper, Nobutaka Fujii. 2006-08-01. Structure-activity relationship study on small peptidic GPR54 agonists.. https://doi.org/10.1016/j.bmc.2006.07.009
Cite the original work for its findings. Save a collection to share your selection of sources.